BioXcel Therapeutics shares are trading higher after the company announced that the Centers for Medicare & Medicaid Services issued a permanent and product-specific J-Code for IGALMI sublingual film.

Bioxcel Therapeutics +0.63% Post

Bioxcel Therapeutics

BTAI

3.17

3.15

+0.63%

-0.63% Post

BioXcel Therapeutics shares are trading higher after the company announced that the Centers for Medicare & Medicaid Services issued a permanent and product-specific J-Code for IGALMI sublingual film.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via